A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Clinical trial NCT03397264 · COMPLETED
Trial details
- NCT number
- NCT03397264
- Sponsor
- Opthea Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-16
- Primary completion
- 2020-03-26
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.